ZA200900483B - Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins - Google Patents
Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteinsInfo
- Publication number
- ZA200900483B ZA200900483B ZA200900483A ZA200900483A ZA200900483B ZA 200900483 B ZA200900483 B ZA 200900483B ZA 200900483 A ZA200900483 A ZA 200900483A ZA 200900483 A ZA200900483 A ZA 200900483A ZA 200900483 B ZA200900483 B ZA 200900483B
- Authority
- ZA
- South Africa
- Prior art keywords
- construction
- mediated insertion
- vector
- recombinant virus
- immunologic determinants
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83101306P | 2006-07-14 | 2006-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900483B true ZA200900483B (en) | 2010-03-31 |
Family
ID=41095676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900483A ZA200900483B (en) | 2006-07-14 | 2007-07-16 | Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101528254A (en) |
ZA (1) | ZA200900483B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101850116B (en) * | 2010-06-18 | 2012-07-04 | 中国人民解放军军事医学科学院军事兽医研究所 | Method for constructing virus live vector recombinant vaccine by utilizing transposon |
CN103328647B (en) * | 2010-09-21 | 2016-05-04 | 廖经伦 | Flavivirus recombinant and application thereof |
EP2959915A1 (en) * | 2014-06-23 | 2015-12-30 | Institut Pasteur | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection |
EP3302574A4 (en) * | 2015-05-26 | 2018-10-17 | Advaxis, Inc. | Personalized delivery vector-based immunotherapy and uses thereof |
CN105400799B (en) * | 2015-12-22 | 2018-12-28 | 成都生物制品研究所有限责任公司 | A kind of hot embedded virus of encephalitis/Huang and its preparation method and application |
-
2007
- 2007-07-16 CN CNA2007800342740A patent/CN101528254A/en active Pending
- 2007-07-16 ZA ZA200900483A patent/ZA200900483B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101528254A (en) | 2009-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196523A0 (en) | Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins | |
HRP20181259T1 (en) | Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells | |
HK1210410A1 (en) | Stabilization of vaccines by lyophilization | |
BRPI1012635A2 (en) | "methods and compositions for virus immunization" | |
EP2035565A4 (en) | Methods of enhancing protein incorporation into virus like particles | |
IL195683A0 (en) | Recombinant viral vaccine | |
EP2396343A4 (en) | Modified virus vectors and methods of making and using the same | |
IL208147A0 (en) | Replication-defective flavivirus vaccines and vaccine vectors | |
IL208241A0 (en) | Heat shock protein gp96 vaccination and methods of using same | |
PL2010209T3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
IL198186A (en) | Mphosph1 derived peptide vaccines | |
PL2419132T3 (en) | Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species | |
EP2234636A4 (en) | Stabilized formulations of peptides and proteins | |
EP2001517A4 (en) | Regulated expression of recombinant proteins from adeno-associated viral vectors | |
SMT201600147B (en) | METHODS TO IMPROVE THE EXPRESSION OF RECOMBINANT PROTEINS | |
ZA200900483B (en) | Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins | |
EP1934335A4 (en) | Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications | |
GB0615635D0 (en) | Immunogenic proteins and uses thereof | |
EP2134361A4 (en) | Compositions and methods for increasing immunogenicity of glycoprotein vaccines | |
IL232461A0 (en) | Melk epitope peptides and vaccines containing the same | |
ZA201104013B (en) | Recombinant inactivated viral vector vaccine | |
EP1841451A4 (en) | Peptides for delivery of mucosal vaccines | |
ZA201101743B (en) | Vaccine comprising protein nmbo964 from meisseria meningitidis | |
BRPI1013938A2 (en) | "ttk peptides and vaccines including them" | |
EP2054081A4 (en) | Jc virus vaccine |